Get Ready for HCPCs: Here’s an Update

The Centers for Medicare and Medicaid Services (CMS) has released a summary of each HCPCS Level II code application decision. The document is twenty-eight pages long and the link can be found in the Resources section.

There are 23 items included in the Second Quarter 2024 Drug and Biological decisions. Twenty new codes have been established. There is one title revision and two code deletions.

TitleDecisionHCPCS CodeDescription
DocivyxTitle RevisionJ9172Change manufacturer from Ingenus to Avyxa
Xenoview™AddA9610Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
 DeleteJ9150Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
Aurlumyn™AddJ1749Inj, iloprost, 0.1mcg
Combogesic ®AddJ0138Inj, acetaminophen 10 mg and ibuprofen 3 mg
Paclitaxol Protein Bound ParticlesDeleteJ9258Inj, paclitaxel protein-bound particles (teva) not therapeutically equivalent to J9264, 1 mg.
Jubbonti & WyostAddQ5136Inj, denosumab-bbdz, biosimilar, 1 mg
TYENNE ®AddQ5135Inj, tocilizumab-aazg, biosimilar, 1 mg
TEVIMBRAAddQ9329Inj, tislelizumab-jsgr, 1 mg
KISUNLA™AddJ0175Inj, donanemab-azbt, 2 mg
Baxter’s Vasopressin in Sodium ChlorideAddJ2601Inj, vasopressin (baxter), 1 unit
Tri-Membrane WrapAddQ4344Tri-membrane wrap, per square centimeter
Dermacyte® AC Matrix Amniotic Membrane AllographAddQ4343Dermatocyte ac matrix amniotic membrane allograph, per square centimeter  
TheraMendAddQ4342Theramend, per square centimeter
Matrix HD Allograft DermisAddQ4345Matrix hd allograft dermis, per square centimeter
Artacent CAddQ4336Artacent c, per square centimeter
Artacent TridentAddQ4337Artacent trident, per square centimeter
Artacent VelosAddQ4338Artacent velos, per square centimeter
Artacent VeriClenAddQ4339Artacent vericlen, per square centimeter
AmnioPlast 1 ™AddQ4334Amnioplast 1, per square centimeter
AmnioPlast 2 ™AddQ4335Amnioplast 2, per square centimeter
SimpliMaxAddQ4341Simplimax, per square centimeter
SimpliGraftAddQ4340Simpligraft, per square centimeter

It is recommended to review the application results to determine when the code becomes active or inactive.

There is also an analysis of HCPCS codes for products approved by the Food and Drug Administration (FDA) under the 505(b)(2) NDA and BLA Pathways and Products Not Otherwise Classified. The results are eight new codes, one revision, and four deletions as shown below:

The release of the application decisions means that the chargemaster coordinator must review the chargemaster to see if the changes impact the file.

Each of the added items should be discussed with the pharmacy department or chief medical officer (CMO) to determine if there is a plan to add these drugs and biologicals to the formulary. Pharmaceuticals can be difficult because of the translation that is made from the units described in the code description to the usual dosage amount.

The HCPCS codes are updated on a quarterly basis so this process should occur with each release. It is important to avoid unnecessary claim denials due to inactive codes or missed charges because the new codes are not available for reporting.

Resources:

2024-hcpcs-application-summary-quarter-2-2024-drugs-and-biologicals.pdf (cms.gov)

Facebook
Twitter
LinkedIn

Laurie M. Johnson, MS, RHIA, FAHIMA, AHIMA Approved ICD-10-CM/PCS Trainer

Laurie Johnson is currently a senior healthcare consultant for Revenue Cycle Solutions, based in Pittsburgh, Pa. Laurie is an AHIMA-approved ICD-10-CM/PCS trainer. She has more than 35 years of experience in health information management and specializes in coding and related functions. She has been a featured speaker in over 40 conferences. Laurie is a member of the ICD10monitor editorial board and is a permanent panelist on Talk Ten Tuesdays

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

The Cost of Ignoring Risk Adjustment: How HCCs Impact Revenue & Compliance

The Cost of Ignoring Risk Adjustment: How HCCs Impact Revenue & Compliance

Stop revenue leakage and boost hospital performance by mastering risk adjustment and HCCs. This essential webcast with expert Cheryl Ericson, RN, MS, CCDS, CDIP, will reveal how inaccurate patient acuity documentation leads to lost reimbursements through penalties from poor quality scores. Learn the critical differences between HCCs and traditional CCs/MCCs, adapt your CDI workflows, and ensure accurate payments in Medicare Advantage and value-based care models. Perfect for HIM leaders, coders, and CDI professionals.  Don’t miss this chance to protect your hospital’s revenue and reputation!

May 29, 2025
I050825

Mastering ICD-10-CM Coding for Diabetes and it’s Complications: Avoiding Denials & Ensuring Compliance

Struggling with ICD-10-CM coding for diabetes and complications? This expert-led webcast clarifies complex combination codes, documentation gaps, and sequencing rules to reduce denials and ensure compliance. Dr. Angela Comfort will provide actionable strategies to accurately link diabetes to complications, improve provider documentation, and optimize reimbursement—helping coders, CDI specialists, and HIM leaders minimize audit risks and strengthen revenue integrity. Don’t miss this chance to master diabetes coding with real-world case studies, key takeaways, and live Q&A!

May 8, 2025
2025 Coding Clinic Webcast Series

2025 ICD-10-CM/PCS Coding Clinic Update Webcast Series

Uncover critical guidance. HIM coding expert, Kay Piper, RHIA, CDIP, CCS, provides an interactive review on important information in each of the AHA’s 2025 ICD-10-CM/PCS Quarterly Coding Clinics in easy-to-access on-demand webcasts, available shortly after each official publication.

April 14, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24